.Amgen has shared (PDF) the initial stage 3 data on its own $400 thousand eczema drug, connecting th...
.Biogen and also UCB's bet one's bottom dollar improving into period 3 on the back of a broken resea...
.Italian biotech Aptadir Therapeutics has launched along with the promise that its pipeline of precl...
.Wave Life Sciences has actually satisfied its own goal in a Duchenne muscular dystrophy (DMD) resea...
.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma crease, us...
.Achilles Rehabs has torn up its own method. The English biotech is actually quiting working on its ...
.Aligos Therapeutics is actually proclaiming a midstage win in metabolic-dysfunction affiliated stea...
.Basilea Pharmaceutica's job cultivating brand new antifungals has received a considerable improveme...
.Possessing presently scooped up the USA liberties to Capricor Therapies' late-stage Duchenne muscle...
.After pushing the decision date for Applied Therapies' metabolic disorder drug govorestat, the FDA ...